Literature DB >> 7438392

M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.

A G Siqueira-Filho, C L Cunha, A J Tajik, J B Seward, T T Schattenberg, E R Giuliani.   

Abstract

Twenty-eight patients with cardiac amyloidosis were studied by echocardiography -- 26 by M-mode and 13 by two-dimensional (2D) studies. All had heart failure and biopsy-proved amyloidosis, M-mode features included (1) normal left ventricular (LV) dimension in all; (2) thickened ventricular septum (88%), LV posterior wall (77%), and right ventricular (RV) anterior wall (79%); (3) decreased thickening of ventricular septum (96%) and of LV posterior wall (65%) and reduced LV global function (62%); (4) left atrial enlargement (50%); and (5) pericardial effusion (58%). Two-dimensional echocardiography provided additional features: (1) thickened papillary muscles (five of 13); (2) thickened valves (four of 13); (3) better appreciation of thickened RV wall; and (4) a characteristic "granular sparkling" appearance of thickened cardiac walls -- presumably secondary to the amyloid deposit -- which was noted in 12 of 13 patients. Thus, M-mode echocardiography is helpful in the recognition of cardiac amyloidosis. However, the better appreciation with 2D echocardiography of thickened cardiac walls with a "granular sparkling" appearance in patients with unexplained cardiac failure is virtually diagnostic of cardiac amyloidosis.

Entities:  

Mesh:

Year:  1981        PMID: 7438392     DOI: 10.1161/01.cir.63.1.188

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  46 in total

1.  Noninvasive diagnosis of cardiac amyloidosis by MRI and echochardiography.

Authors:  Jing Wang; Xiangquan Kong; Haibo Xu; Guofeng Zhou; Dandan Chang; Dingxi Liu; Li Zhang; Mingxing Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

2.  Therapy effects of green tea in a patient with systemic light-chain amyloidosis.

Authors:  Derliz Mereles; Erich E Wanker; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2008-03-03       Impact factor: 5.460

3.  The value of conventional echocardiographic and tissue doppler imaging in the diagnosis of cardiac amyloidosis.

Authors:  Li Zhang; Mingxing Xie; Xinfang Wang; Yali Yang; Junhong Huang; Ming Cheng; Feixiang Xiang; Qing Lü
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

4.  Effusive reasoning.

Authors:  Brandon Erickson; Gurpreet Dhaliwal; Mark C Henderson; Ezra Amsterdam; Joseph Rencic
Journal:  J Gen Intern Med       Date:  2011-07-15       Impact factor: 5.128

Review 5.  Restrictive cardiomyopathy.

Authors:  P T Wilmshurst; D Katritsis
Journal:  Br Heart J       Date:  1990-06

6.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

Review 7.  Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging.

Authors:  Dalia Di Nunzio; Antonino Recupero; Cesare de Gregorio; Concetta Zito; Scipione Carerj; Gianluca Di Bella
Journal:  Curr Cardiol Rep       Date:  2019-02-12       Impact factor: 2.931

8.  A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation.

Authors:  T Kobayashi; M Sekiya; Y Fujiwara; T Sumimoto; H Matsuoka; M Hamada; K Hiwada
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

Review 9.  Right ventricular failure complicating heart failure: pathophysiology, significance, and management strategies.

Authors:  Mobusher Mahmud; Hunter C Champion
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

10.  Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy.

Authors:  P Eriksson; C Backman; P Bjerle; A Eriksson; S Holm; B O Olofsson
Journal:  Br Heart J       Date:  1984-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.